Injectable living marrow stromal cell-based autologous tissue engineered heart valves: First experiences with a one-step intervention in primates

European Heart Journal

Volumn 32, Issue 22, 2011, Pages 2830-2840

  Weber, Benedikt ^a,b   Scherman, Jacques ^c,d   Emmert, Maximilian Y ^a,b   Gruenenfelder, Juerg ^b   Verbeek, Renier ^d   Bracher, Mona ^d   Black, Melanie ^d   Kortsmit, Jeroen ^d   Franz, Thomas ^d   Schoenauer, Roman ^a,b   Baumgartner, Laura ^a,b   Brokopp, Chad ^a,b   Agarkova, Irina ^a,b   Wolint, Petra ^a,b   Zund, Gregor ^a,b   Falk, Volkmar ^b   Zilla, Peter ^c,d   Hoerstrup, Simon P ^a,b  

^a Swiss Center for Regenerative Medicine   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bone marrow; Heart valve; Minimally invasive; Primate model; Stem cells; Tissue engineering

Indexed keywords

TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MARROW CELL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART VALVE; HEART VALVE REPLACEMENT; HEMATOPOIETIC STEM CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE; MINIMALLY INVASIVE PROCEDURE; MONONUCLEAR CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PULMONARY VALVE REPLACEMENT; SCANNING ELECTRON MICROSCOPY; STROMA CELL; TISSUE ENGINEERED HEART VALVE; TISSUE ENGINEERING;

ANIMALS; BIOPROSTHESIS; FEASIBILITY STUDIES; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART VALVE PROSTHESIS; INJECTIONS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; MONOCYTES; PAPIO URSINUS; PULMONARY VALVE; STEM CELL TRANSPLANTATION; STENTS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 80054072951     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr059     Document Type: Article

References (45)

1. Supino PG, Borer JS, Preibisz J. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin 2006;2:379-393. (Pubitemid 46590077)
2. Lurz P, Bonhoeffer P, Taylor AM. Percutaneous pulmonary valve implantation: an update. Expert Rev Cardiovasc Ther 2009;7:823-833.
3. Asoh K, Walsh M, Hickey E, Nagiub M, Chaturvedi R, Lee KJ, Benson LN. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur Heart J 2010;31:1404-1409.
4. Momenah TS, El Oakley R, Al Najashi K, Khoshhal S, Al Qethamy H, Bonhoeffer P. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009;53:1859-1863.
5. Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Rückert Y, Ender J, Linke A, Scholz M, Falk V, Mohr FW. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010;31:1398-1403.
6. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;611:I240-I245. (Pubitemid 47480797)
7. Fernandes SM, Khairy P, Sanders SP, Colan SD. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol 2007;49: 2211-2214. (Pubitemid 46824114)
8. Schmidt D, Dijkman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, Rissanen M, Deichmann T, Odermatt B, Weber B, Emmert MY, Zund G, Baaijens FPT, Hoerstrup SP. Minimally invasive implantation of living tissue engineered heart valves-a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 2010;56:510-520.
9. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106:I143-I150.
10. Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC Jr, Sacks MS, Schoen FJ, Mayer JE Jr. From stem cells to viable autologous semilunar heart valve. Circulation 2005;111: 2783-2791. (Pubitemid 40791550)
11. Schmidt D, Mol A, Breymann C, Achermann J, Odermatt B, Gössi M, Neuenschwander S, Prêtre R, Genoni M, Zund G, Hoerstrup SP. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006;114:I125-I131. (Pubitemid 44297140)
12. Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, Zund G, Hoerstrup SP. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007;116: I64-I70. (Pubitemid 47480771)
13. Hibino N, Shin'oka T, Matsumura G, Ikada Y, Kurosawa H. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg 2005; 129:1064-1070. (Pubitemid 40631427)
14. Matsumura G, Ishihara Y, Miyagawa-Tomita S, Ikada Y, Matsuda S, Kurosawa H, Shin'oka T. Evaluation of tissue-engineered vascular autografts. Tissue Eng 2006; 12:3075-3083. (Pubitemid 44846413)
15. Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008; 248:370-377.
16. Mirensky TL, Nelson GN, Brennan MP, Roh JD, Hibino N, Yi T, Shinoka T, Breuer CK. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg 2009;44:1127-1132.
17. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 2010;107: 4669-4674.
18. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001;344:532-533.
19. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729-1734. (Pubitemid 37243662)
20. Isomatsu Y, Shin'oka T, Matsumura G, Hibino N, Konuma T, Nagatsu M, Kurosawa H. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 2003;126:1958-1962. (Pubitemid 38020758)
21. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-1338.
22. Mol A, van Lieshout MI, Dam-de Veen CG, Neuenschwander S, Hoerstrup SP, Baaijens FP, Bouten CV. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 2005;26:3113-3121. (Pubitemid 39647246)
23. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
24. Cesarone CF, Bolognesi C, Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 1979;100: 188-197. (Pubitemid 10157650)
25. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 1986;883:173-177. (Pubitemid 16027978)
26. Huszar G, Maiocco J, Naftolin F. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem 1980;105:424-429. (Pubitemid 11237545)
27. Bonhoeffer P, Boudjemline Y, Qureshi SA, Le Bidois J, Iserin L, Acar P, Merckx J, Kachaner J, Sidi D. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002;39:1664-1669. (Pubitemid 34494291)
28. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703. (Pubitemid 38229547)
29. Coats L, Bonhoeffer P. New percutaneous treatments for valve disease. Heart 2007;93:639-644. (Pubitemid 46707121)
30. Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008;118:1864-1880.
31. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, Giacca M. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006; 107:3546-3554.
32. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668. (Pubitemid 38524810)
33. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673. (Pubitemid 38524811)
34. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297: 2256-2259.
35. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-545. (Pubitemid 34288856)
36. Nygren JM, Jovinge S, Breitbach M, Säwén P, Röll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10:494-501. (Pubitemid 38667908)
37. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549. (Pubitemid 38420184)
38. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11: 367-368. (Pubitemid 40562318)
39. O'Neill TJ IV,Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrowderived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005;97:1027-1035. (Pubitemid 41668916)
40. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006; 98:1414-1421. (Pubitemid 43948066)
41. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080. (Pubitemid 40288798)
42. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng 2000;61:75-79. (Pubitemid 30123985)
43. Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Bouten CV, Baaijens FP. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 2005;33:1778-1788. (Pubitemid 43037548)
44. Flanagan TC, Sachweh JS, Frese J, Schnöring H, Gronloh N, Koch S, Tolba RH, Schmitz-Rode T, Jockenhoevel S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 2009;15:2965-2976.
45. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature 2009;462:433-441.